Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.22B | $3.16B | $2.21B | $2.21B | $2.21B | $199.0M | $1.98B | $1.43B |
| Cost of revenue | $1.74B | $1.74B | $1.54B | $1.32B | $1.32B | $62.8M | $1.15B | $787.8M |
| Gross profit | $1.47B | $1.42B | $669.4M | $891.7M | $891.7M | $136.2M | $827.1M | $642.8M |
| Gross margin | 45.8% | 44.9% | 30.2% | 40.4% | 40.4% | 68.5% | 41.8% | 44.9% |
| R&D | $361.1M | $349.4M | $290.8M | $205.2M | $205.2M | $31.3M | $115.7M | $90.7M |
| Operating income | −$3.72B | $314.1M | −$492.2M | $128.6M | −$1.05B | $8.7M | $90.2M | −$457.5M |
| EBITDA | $1.17B | $41.2M | $185.5M | $313.2M | −$723.5M | −$6.5M | $960.0M | $130.5M |
| Net income | −$3.61B | −$1.01B | −$969.7M | −$723.5M | −$717.4M | −$11.9M | $477.9M | −$489.5M |
| Net margin | -112.2% | -31.8% | -43.8% | -32.8% | -32.5% | -6.0% | 24.1% | -34.2% |
| EPS (diluted) | -42.94 | -12.00 | -11.48 | -8.54 | -3.51 | -0.04 | 24.14 | -17.48 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds MNK.
No tracked institution reports a position in MNK as of their last filing.
No one on the platform has traded MNK yet.
| $4M |
| — |
| MDGSXylo Technologies Ltd. | $2.36 | +10.28% | $179M | — |
| NBRVFNabriva Therapeutics plc | $0.00 | +0.00% | $323 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.